In-vitro Fertilization (IVF) Market Size

  • Report ID: 6483
  • Published Date: Sep 18, 2025
  • Report Format: PDF, PPT

In-vitro Fertilization Market Outlook:

In-vitro Fertilization Market size was over USD 27.06 billion in 2025 and is anticipated to cross USD 50.8 billion by 2035, growing at more than 6.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of in-vitro fertilization is assessed at USD 28.64 billion.

The in-vitro fertilization market has witnessed significant growth in recent years, driven by the increasing infertility rate, reproductive technologies advancement, and evolving social trends. Furthermore, rising awareness of fertility treatments and the growing availability of IVF services have further fueled the market.

Embryo selection techniques and effective lab equipment are some of the recent advancements in IVF technology enhancing the treatment success rate and, in turn becoming a more attractive option. Additionally, supportive government policies and insurance coverage in some regions are expanding access to these treatments. Prominent market players are also involving several R&Ds, new launches, and innovation activities. For instance, in June 2023, FUJIFILM Irvine Scientific, Inc. announced the addition of the Life Whisperer Genetics module to its Life Whisperer software package. The launch was aimed at enabling non-invasive evaluation of embryo genetic integrity during in vitro fertilization (IVF).


In-vitro Fertilization Market size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of in-vitro fertilization is assessed at USD 28.64 billion.

The global in-vitro fertilization market size surpassed USD 27.06 billion in 2025 and is projected to grow at a CAGR of more than 6.5%, reaching USD 50.8 billion revenue by 2035.

North America in-vitro fertilization (IVF) market will account for 30.50% share by 2035, driven by developed healthcare infrastructure, IVF technology advancements, and a well-regulated medical industry.

Key players in the market include CooperSurgical, Inc., Vitrolife AB, Cook Medical, Inc., Merck KGaA, Ferring Pharmaceuticals, Irvine Scientific (FUJIFILM), Thermo Fisher Scientific Inc., Genea Biomedx, OvaScience, Inc., Progyny, Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos